Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
January 2025
in “
Cutis
”
Studysummary This review examined the dermatologic side effects and potential treatments benefits of metformin and GLP-1/GIP agonists in managing skin conditions related to hormonal and immune effects in individuals with type 2 diabetes who are overweight or obese. Our plain-language summary of this paper — not a Tressless recommendation.
This review discusses the dermatologic implications of glycemic control medications for patients with Type 2 diabetes mellitus (T2DM), focusing on metformin and GLP-1 and GLP-1/GIP agonists. While these medications are primarily used to improve blood glucose levels and insulin sensitivity, they also have hormonal and immunologic effects that can impact dermatologic conditions such as psoriasis and hidradenitis suppurativa. The review highlights both the adverse effects and potential therapeutic benefits of these medications on skin health in T2DM patients.
